LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹38 Cr | ₹57 Cr | ₹72 Cr | ₹130 Cr | ₹162 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹162 Cr |
How is Total Debt of LYKA LABS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -32.99 | |
| Mar2024 | ₹57 Cr | -21.44 | |
| Mar2023 | ₹72 Cr | -44.54 | |
| Mar2022 | ₹130 Cr | -19.86 | |
| Mar2021 | ₹162 Cr | - | |
Compare Total Debt of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹249.2 Cr | 21.6% | 12.6% | -46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 21.6% |
12.6% |
-46.8% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses